Neutral impactIPO
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Economic Times 53 min ago·19 Aug 2026, 3:34 am
Symbiotec Pharmalab is set to launch its initial public offering (IPO) on August 24, 2026. The company aims to raise approximately Rs 1,757 crore through this fresh issue of shares. The IPO will be open for subscription from August 24 to August 27, with a price band of Rs 938 to Rs 988 per share. Investors can bid for a minimum of 15 shares, which would require an investment of Rs 14,820 at the upper price band. The company plans to list its shares on both the BSE and NSE on September 1, with allotment expected to be finalized by August 28.
For investors, the IPO offers a chance to participate in the growth of a pharmaceutical company. The issue is priced at a premium, with the company valued at 52 times its diluted earnings per share (EPS) for FY26. This high valuation reflects market expectations about the company's future performance. Investors should carefully evaluate the company's financials and growth prospects before subscribing to the issue. It is also important to consider the overall market conditions and the performance of similar IPOs in the past.
Key takeaways
- Category: IPO.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.
